版本:
中国

BRIEF-Cellectar Biosciences receives Japanese patent for CLR 131 and CLR 125

April 18 Cellectar Biosciences Inc

* Cellectar Biosciences receives Japanese patent for CLR 131 and CLR 125 for treatment of cancer stem cells Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐